文献
J-GLOBAL ID:201702241006897870
整理番号:17A1456785
グラム陽性病原体によるに院内肺炎疑いのあるまたは確認されの治療のための静脈内イクラプリムとバンコマイシンの有効性と安全性を評価する第2相無作為化二重盲検多施設共同研究【Powered by NICT】
A Phase II Randomized, Double-blind, Multicenter Study to Evaluate Efficacy and Safety of Intravenous Iclaprim Versus Vancomycin for the Treatment of Nosocomial Pneumonia Suspected or Confirmed to be Due to Gram-positive Pathogens
著者 (8件):
Huang David B.
(Motif BioSciences, New York, New York)
,
File Thomas M.
(Summa Health, Akron, Ohio)
,
Torres Antoni
(Department of Pulmonology, Hospital Clinic of Barcelona, University of Barcelona, Institut D’investigacions August Pi I Sunyer, and Centro de Investigacion Biomedica En Red-Enfermedades Respiratorias, Barcelona, Spain)
,
Shorr Andrew F.
(Section of Pulmonary and Critical Care Medicine, MedStar Washington Hospital Center, Washington, DC)
,
Wilcox Mark H.
(Leeds Teaching Hospitals and University of Leeds, Leeds, United Kingdom)
,
Hadvary Paul
(Hemex AG, Liestal, Switzerland)
,
Dryden Matthew
(Department of Microbiology and Infection, Hampshire Hospitals NHS Foundation Trust, Southampton, United Kingdom)
,
Corey G. Ralph
(Duke University Medical Center, Durham, North Carolina)
資料名:
Clinical Therapeutics
(Clinical Therapeutics)
巻:
39
号:
8
ページ:
1706-1718
発行年:
2017年
JST資料番号:
A1157A
ISSN:
0149-2918
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)